Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Arjuna bark contains arjunolic acid and arjungenin, which preserve glutathione levels and inhibit lipid peroxidation through anti-apoptotic signaling pathways. These triterpene compounds demonstrate cardioprotective effects by reducing oxidative stress in cardiac cells and modulating inflammatory responses.
Reported Benefits (Provisional)
Origin & History
Arjuna Bark, derived from *Terminalia arjuna*, is indigenous to the Indian subcontinent and also found in tropical rainforests along riverbanks in Brazil, Bolivia, and Peru. This revered botanical is a cornerstone of Ayurvedic medicine, primarily valued for its profound cardioprotective properties and adaptogenic support.
Research Narrative (Provisional)
Arjuna Bark is extensively studied for its cardioprotective and adaptogenic properties, with research published in peer-reviewed journals. Clinical studies and meta-analyses support its efficacy in strengthening heart muscles, regulating blood pressure, and modulating cholesterol levels, validating its long-standing traditional use.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Triterpenoids: Arjunolic acid, arjunic acid, arjunetin (Cardioprotective, hepatoprotective). - Flavonoids: Potent antioxidants and anti-inflammatory compounds. - Tannins, Saponins: Contribute to cholesterol regulation, digestive health, and immune function. - Minerals: Magnesium, Calcium, Potassium, Zinc, Phosphorus (Support muscle, bone, blood pressure, and immune functions). - B Vitamins: Essential for cognitive function and energy metabolism.
Reported Mechanism (Provisional)
Arjunolic acid preserves cellular glutathione and ascorbic acid levels while inhibiting myeloperoxidase and lipid peroxidation through anti-apoptotic signaling pathways. Arjungenin demonstrates moderate free radical scavenging activity with an IC50 of 60 μg/ml against superoxide radicals and inhibits respiratory oxidative burst in neutrophils. Terminoside A reduces inflammatory responses by inhibiting nitric oxide production and inducible nitric oxide synthase in activated macrophages.
Clinical Narrative (Provisional)
Current evidence is primarily based on in vitro and animal studies, with arjungenin showing free radical scavenging comparable to vitamin C (IC50 290.6 µg/ml). Ethanolic extracts demonstrate DPPH, ABTS, hydroxyl, and nitric oxide radical scavenging activities correlated with phenolic and flavonoid content. Antimutagenic effects have been documented in lymphocyte and mouse bone marrow assays, reducing chromosomal abnormalities and sister chromatid exchanges. However, human clinical trials with specific cardiovascular outcomes and sample sizes are lacking in current literature.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.